Menu Close

Carnicolin suspension 60ml

150,00 EGP

Carnicolin Suspension 60ml combines Citicoline, L-Carnitine, and Coenzyme Q10 to support brain health, sharpen focus, and improve memory. Clinically supported for managing mental and motor disorders in children, meeting FDA and EFSA standards for evidence-based neurological care.

Description

Carnicolin Suspension 60ml is an advanced formulation that combines the synergistic power of Citicoline, L-Carnitine, and Coenzyme Q10 to provide comprehensive support for brain health and cognitive performance.

Cognitive Performance By optimizing mitochondrial energy production and enhancing neurotransmitter synthesis, this supplement is meticulously designed to sharpen focus, improve memory, and support overall neurological function.

Neurodevelopmental Support Offers documented advantages in managing mental and motor disorders in children, providing targeted support for neurodevelopmental well-being and healthy brain maturation.

Clinically Evidenced Backed by clinical evidence and international standards including FDA, EFSA, and peer-reviewed literature such as the Nutrients journal — ensuring a safe, reliable, and evidence-based formulation.

Premium Active Ingredients This potent blend of Citicoline, L-Carnitine, and Coenzyme Q10 works synergistically to enhance brain health, improve mental clarity, and optimize neurological function for both children and adults seeking comprehensive cognitive support.

SCIENTIFIC EXCELLENCE

Clinical Efficacy & Analytics

Carnicolin increases the probability of complete recovery at 3 months with moderate to severe stroke

Reduce central nervous system ischemic injury by stabilizing cell membranes & reducing free radical generation.

% of complete recovery at 3 months in Citicoline group
25%
% of complete recovery at 3 months in placebo group
20%

% of complete recovery at 3 months

20.2
25.2

Patient Recovery Index (Global Recovery Test / Global Measure of Outcome)

25.2% of patients in the citicoline group achieved full recovery (defined as NIHSS < 1, mRS < 1, and Barthel Index > 95) at 3 months, compared to 20.2% of patients in the placebo group (p = 0.0034)

Reviews

There are no reviews yet.

Be the first to review “Carnicolin suspension 60ml”

Your email address will not be published. Required fields are marked *